Programs that Stand up to Scrutiny
Our Scientific Advisory Board holds us to the highest standards of scientific practice.
View Advisory Board*3 additional respiratory programs in collaboration with AstraZeneca, 2 of which carry co-development and co-commercialization options for Pieris
**Collaboration includes 1 respiratory program and 1 ophthalmology program
‡ 3 bispecific programs (2 active; 1 forthcoming) in collaboration with Seagen.
*Company no longer enrolling the phase 2 study